Contrasting Daxor (NASDAQ:DXR) and Titan Medical (NASDAQ:TMDIF)

Daxor (NASDAQ:DXR) and Titan Medical (NASDAQ:TMDIF) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, analyst recommendations, valuation, earnings, risk, institutional ownership and profitability.

Insider and Institutional Ownership

1.3% of Daxor shares are owned by institutional investors. Comparatively, 0.0% of Titan Medical shares are owned by institutional investors. 59.0% of Daxor shares are owned by company insiders. Comparatively, 0.0% of Titan Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Profitability

This table compares Daxor and Titan Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Daxor	N/A	N/A	N/A
Titan Medical	N/A	-82.31%	-51.47%

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for Daxor and Titan Medical, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Daxor	0	0	1	0	3.00
Titan Medical	0	0	0	0	0.00

Daxor currently has a consensus target price of $24.75, indicating a potential upside of 206.69%. Given Daxor’s stronger consensus rating and higher possible upside, analysts clearly believe Daxor is more favorable than Titan Medical.

Risk and Volatility

Daxor has a beta of -0.46, suggesting that its share price is 146% less volatile than the S&P 500. Comparatively, Titan Medical has a beta of 1.26, suggesting that its share price is 26% more volatile than the S&P 500.

Valuation & Earnings

This table compares Daxor and Titan Medical”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Daxor	$2.61 million	14.98	N/A	N/A	N/A
Titan Medical	$17.63 million	3.10	$6.95 million	$0.05	9.58

Titan Medical has higher revenue and earnings than Daxor.

Summary

Daxor beats Titan Medical on 8 of the 10 factors compared between the two stocks.

About Daxor

Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee. Daxor Corporation is a subsidiary of Estate Of Joseph Feldschuh.

About Titan Medical

Titan Medical Inc. operates as a medical technology company. It focuses on the development and licensing of robotic assisted surgical technologies. The company is headquartered in Toronto, Canada.